PracticeVideosBlogFlashcardsEspañol
All Practice Exams

Free Practice Questions for EHPLE Pharmacy

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Ethiopian Health Professionals Licensing Examination (EHPLE)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Ethiopian Health Professionals Licensing Examination — Anesthesia

Practice Questions

Ethiopian Health Professionals Licensing Examination — Dental Medicine

Practice Questions

Ethiopian Health Professionals Licensing Examination — Environmental Health

Practice Questions

Ethiopian Health Professionals Licensing Examination — Medical Laboratory Science

Practice Questions

Ethiopian Health Professionals Licensing Examination — Medical Radiology Technology

Practice Questions

Ethiopian Health Professionals Licensing Examination — Medicine (MD)

Practice Questions
Exam Review

Key Facts: EHPLE Pharmacy Exam

200 MCQs

Total questions on the national CBT examination

MoH HHrIPR-LEO Blueprint

Two blocks of 100

Total examination duration (a morning and an afternoon block of 100 questions each)

MoH Implementation Guideline (blocks of <=120 questions, >=30-minute break)

Not published

Official registration fee per round

MoH registration portal (hple.moh.gov.et)

7 Domains

Core competency areas assessed on the exam

HHrIPR-LEO BPharm Blueprint

Modified Angoff

Standard-setting method for cut score determination

MoH Psychometric Standards

The EHPLE Pharmacy exam is Ethiopia's mandatory national licensing test for BPharm graduates, administered by the Ministry of Health's HHrIPR-LEO as 200 four-option MCQs in a morning and an afternoon block of 100 questions each. The official MoH blueprint weights Patient Care 53% (pharmaceutical care 25%, dispensing 21%, drug information 7%), Leadership and Management 14% (supply chain management 12%), Pharmaceutical Technology 12%, Pharmacy Law and Regulatory Affairs 10%, Professionalism 5%, Health Promotion and Disease Prevention 3%, and Scholar 3%. The pass mark is set each round by a Modified-Angoff expert panel.

Sample EHPLE Pharmacy Practice Questions

Try these sample questions to review concepts for the EHPLE Pharmacy exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Which pharmacological mechanism explains the clinical action of atropine in reversing organophosphate-induced bradycardia and excessive secretions?
A.Competitive antagonism of muscarinic acetylcholine receptors at parasympathetic postganglionic neuroeffector sites
B.Competitive blockade of nicotinic acetylcholine receptors at neuromuscular junctions
C.Non-competitive inhibition of acetylcholinesterase in synaptic clefts
D.Direct stimulation of beta-1 adrenergic receptors in cardiac nodal tissue
Explanation: Atropine is a prototypical tertiary amine antimuscarinic agent that reversibly competes with acetylcholine for postganglionic muscarinic receptors (M1 through M5). By blocking parasympathetic input to the sinoatrial node and exocrine glands, it reverses life-threatening bradycardia, bronchorrhea, and bronchospasm. It does not bind to nicotinic receptors at therapeutic concentrations and has no direct effect on beta-adrenergic receptors.
2A patient with newly diagnosed essential hypertension begins enalapril therapy. Which mechanism accounts for both the antihypertensive efficacy and the potential development of a persistent dry cough?
A.Direct vasodilation of peripheral arterioles and selective stimulation of pulmonary mast cell degranulation
B.Competitive antagonism of angiotensin II type 1 (AT1) receptors with secondary stimulation of AT2 receptors
C.Inhibition of angiotensin-converting enzyme, preventing angiotensin II synthesis and blocking the degradation of bradykinin and substance P
D.Blockade of calcium influx through L-type voltage-dependent calcium channels in vascular smooth muscle
Explanation: Enalapril is a prodrug converted to enalaprilat, which competitively inhibits angiotensin-converting enzyme (kininase II). This prevents conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing systemic vascular resistance and aldosterone secretion. Because ACE also degrades pro-inflammatory kinins, its inhibition causes accumulation of bradykinin and substance P in pulmonary tissues, triggering the characteristic persistent dry cough.
3What is the primary bactericidal mechanism of third-generation cephalosporins such as ceftriaxone?
A.Irreversible binding to the 30S ribosomal subunit, inducing codon misreading and premature translation termination
B.Covalent binding to penicillin-binding proteins (PBPs), inhibiting the transpeptidase cross-linking of peptidoglycan chains
C.Inhibition of bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, preventing DNA supercoiling
D.Disruption of bacterial cell membrane phospholipid architecture, causing rapid leakage of intracellular electrolytes
Explanation: Ceftriaxone is a broad-spectrum beta-lactam cephalosporin that acylates transpeptidase enzymes (penicillin-binding proteins, especially PBP-1 and PBP-3) located on the outer surface of bacterial inner membranes. This prevents the final cross-linking transpeptidation step of peptidoglycan synthesis, weakening the bacterial cell wall and causing osmotic lysis mediated by endogenous autolysins. It possesses negligible activity against mammalian cell membranes.
4How do benzodiazepines such as diazepam produce their sedative, anxiolytic, and anticonvulsant actions at the molecular level?
A.Direct agonist activation of GABA-B metabotropic receptors coupled to G-protein inward potassium rectifiers
B.Blockade of presynaptic reuptake transporters for gamma-aminobutyric acid (GAT-1), elevating synaptic GABA concentrations
C.Direct opening of ligand-gated chloride channels independently of endogenous GABA neurotransmitter concentration
D.Allosteric modulation of GABA-A receptors, increasing the frequency of chloride channel opening in response to GABA
Explanation: Benzodiazepines bind to a specific allosteric site at the alpha/gamma subunit interface of pentameric GABA-A receptor-chloride channel complexes. This binding induces a conformational shift that potentiates the affinity of GABA for its binding site, thereby increasing the opening frequency of the chloride channel and producing hyperpolarizing inhibitory postsynaptic potentials. Benzodiazepines do not act as direct channel agonists and do not increase channel open duration, which is characteristic of barbiturates.
5Through which molecular target do second-generation sulfonylureas like glibenclamide stimulate insulin secretion from pancreatic beta cells?
A.Inhibition of ATP-sensitive potassium (K-ATP) channels, causing membrane depolarization and calcium influx
B.Inhibition of dipeptidyl peptidase-4 (DPP-4), prolonging the half-life of endogenous incretin hormones
C.Activation of glucagon-like peptide-1 (GLP-1) receptors coupled to adenylate cyclase
D.Peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation, increasing insulin gene transcription
Explanation: Sulfonylureas bind specifically to the SUR1 regulatory subunit of ATP-sensitive inward-rectifier potassium (K-ATP) channels in the pancreatic beta-cell membrane. This inhibits potassium efflux, leading to cell membrane depolarization, opening of voltage-gated L-type calcium channels, calcium influx, and exocytotic release of stored preformed insulin granules. Because their action is independent of ambient glucose, they carry a distinct risk of hypoglycemia.
6Which cellular mechanism is responsible for the positive inotropic effect of digoxin in the management of congestive heart failure?
A.Stimulation of cardiac beta-1 adrenergic receptors, activating the adenylyl cyclase-cAMP-PKA pathway
B.Direct agonism of myocardial ryanodine receptor type 2 channels, increasing sarcoplasmic reticulum calcium release
C.Reversible inhibition of the sarcolemmal Na+/K+-ATPase pump, increasing intracellular sodium and subsequent calcium accumulation via the Na+/Ca2+ exchanger
D.Inhibition of cardiac phosphodiesterase isoenzyme III, preventing intracellular breakdown of cyclic AMP
Explanation: Digoxin binds reversibly to the extracellular alpha subunit of the sarcolemmal sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) pump, inhibiting active sodium extrusion. The resulting rise in intracellular sodium concentration reduces the electrochemical gradient driving the sodium-calcium exchanger (NCX), decreasing calcium extrusion and enhancing sarcoplasmic reticulum calcium loading. During subsequent action potentials, increased calcium is released to interact with troponin C, increasing myocardial contractility.
7Which pair of major organ toxicities necessitates close therapeutic drug monitoring and dosage adjustment during systemic gentamicin therapy?
A.Hepatotoxicity and bone marrow suppression
B.Peripheral neuropathy and optic neuritis
C.Pulmonary fibrosis and thyroid dysfunction
D.Nephrotoxicity and ototoxicity
Explanation: Gentamicin is an aminoglycoside antibiotic that selectively accumulates in renal proximal tubular cells (causing acute tubular necrosis and non-oliguric acute kidney injury) and in the sensory hair cells of the cochlea and vestibular labyrinth (causing irreversible hearing loss, tinnitus, and ataxia). Because toxicity correlates with elevated trough concentrations and total cumulative exposure, serum concentration monitoring and renal function assessments are mandatory during prolonged therapy.
8Why is metoprolol clinically preferred over propranolol when treating hypertension or angina in a patient with a history of mild asthma?
A.Metoprolol possesses intrinsic sympathomimetic activity that directly stimulates beta-2 receptors in bronchial smooth muscle
B.Metoprolol is cardioselective for beta-1 receptors, causing less antagonism of bronchodilatory beta-2 receptors at standard therapeutic doses
C.Metoprolol undergoes rapid esterase hydrolysis in lung tissue, preventing pulmonary accumulation
D.Propranolol acts as an irreversible antagonist at muscarinic M3 receptors, inducing bronchoconstriction
Explanation: Metoprolol is a second-generation, cardioselective beta-adrenergic antagonist with significantly higher affinity for beta-1 receptors in myocardial tissue than for beta-2 receptors in vascular and bronchial smooth muscle. In contrast, propranolol is a non-selective beta-blocker that blocks both beta-1 and beta-2 receptors with equal potency, precipitating severe bronchospasm in asthmatic patients. However, cardioselectivity is dose-dependent and can be lost at high dosages.
9Which enzyme is competitively inhibited by methotrexate, and which rescue agent is administered to prevent lethal bone marrow toxicity during high-dose regimens?
A.Dihydrofolate reductase (DHFR); rescued by folinic acid (leucovorin)
B.Thymidylate synthase; rescued by uridine triacetate
C.Ribonucleotide reductase; rescued by cobalamin (vitamin B12)
D.DNA polymerase alpha; rescued by pyridoxine (vitamin B6)
Explanation: Methotrexate is an antimetabolite that competitively and reversibly inhibits dihydrofolate reductase (DHFR), preventing the conversion of dihydrofolate to active tetrahydrofolate. This starves the cell of one-carbon donors necessary for purine and dTMP synthesis, halting DNA replication. High-dose methotrexate therapy requires rescue with folinic acid (leucovorin, 5-formyl-THF), which bypasses DHFR to replenish reduced folate pools in healthy cells.
10In acute paracetamol (acetaminophen) overdose, what is the biochemical cause of centrilobular hepatic necrosis, and what is the specific pharmacological antidote?
A.Direct mitochondrial uncoupling by paracetamol glucuronide; antidote is deferoxamine
B.Inhibition of hepatic cytochrome P450 2E1 leading to lipid peroxidation; antidote is flumazenil
C.Depletion of hepatic glutathione by the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI); antidote is N-acetylcysteine
D.Excessive accumulation of toxic sulfate conjugates causing biliary stasis; antidote is pralidoxime
Explanation: At therapeutic doses, paracetamol is mostly conjugated with glucuronide and sulfate, with a small fraction oxidized by CYP2E1 to NAPQI, which is rapidly neutralized by hepatic glutathione. In overdose, sulfation and glucuronidation pathways saturate, shunting excess drug through CYP2E1; once glutathione stores are depleted by over 70%, NAPQI binds covalently to hepatic centrilobular macromolecules, causing fulminant necrosis. N-acetylcysteine acts as a glutathione precursor and sulfhydryl donor to detoxify NAPQI.

About the EHPLE Pharmacy Exam

The Ethiopian Health Professionals Licensing Examination (EHPLE) for Pharmacy is the mandatory national licensing assessment established by the Federal Ministry of Health (MoH) through the Health and Health-related Institutions and Professionals Regulatory Lead Executive Office (HHrIPR-LEO). All graduating Bachelor of Pharmacy (BPharm) and Bachelor of Science in Pharmacy candidates from Ethiopian public and private higher education institutions, as well as foreign-trained pharmacy graduates seeking professional registration in Ethiopia, must pass this comprehensive assessment. Passing the EHPLE validates professional competency to practice in hospital pharmacies, community pharmacies, regulatory agencies (EFDA), supply chain facilities (EPSS), and pharmaceutical manufacturing plants across Ethiopia. This practice question bank features 100 high-yield multiple-choice questions with comprehensive clinical rationales aligned directly with the official HHrIPR-LEO curriculum and Ethiopian Standard Treatment Guidelines.

Exam sponsor: Federal Ministry of Health (MoH) — Health and Health-related Institutions and Professionals Regulatory Lead Executive Office (HHrIPR-LEO). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The MoH Implementation Guideline allots roughly 1.25 minutes per question and caps a single block at 120 questions / 2 hours 30 minutes, followed by a break of at least 30 minutes before the second block. A 200-item sitting is therefore delivered as a morning and an afternoon block of 100 questions each.

Time Limit

Two 100-question blocks with a break of at least 30 minutes

Passing Score

Set each round by an expert panel using the Modified-Angoff method (no fixed percentage)

Exam / Certification Fees

Not published by MoH as a fixed public tariff. A registration fee is paid through the official portal (hple.moh.gov.et); candidates who miss a sitting without an accepted reason pay the registration fee plus a 50% penalty (MoH Exam Administration Manual). Confirm the current amount on the registration announcement.

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

53%

Patient Care

Pharmaceutical care (25%), dispensing (21%), and drug information systems (7%).

14%

Leadership and Management

Health commodities supply chain management (12%) and management/leadership (2%).

12%

Pharmaceutical Technology

Pharmaceutical development and manufacturing (11%) and drug discovery (1%).

10%

Pharmacy Law and Regulatory Affairs

Institution regulation (4%), product regulation (4%), professional regulation (1%), and pharmacy law (1%).

5%

Professionalism

Ethical principles (2%), communication and collaboration (2%), and standards of professional conduct and practice (1%).

3%

Health Promotion and Disease Prevention

Community assessment and community-based preventive and promotive interventions.

3%

Scholar

Research literacy, evidence-based pharmacy practice, and continuing professional development.

Preparing for the EHPLE Pharmacy Exam

What You Need to Know

  • Passing score: Set each round by an expert panel using the Modified-Angoff method (no fixed percentage)
  • Assessment: The MoH Implementation Guideline allots roughly 1.25 minutes per question and caps a single block at 120 questions / 2 hours 30 minutes, followed by a break of at least 30 minutes before the second block. A 200-item sitting is therefore delivered as a morning and an afternoon block of 100 questions each.
  • Time limit: Two 100-question blocks with a break of at least 30 minutes
  • Exam / certification fees: Not published by MoH as a fixed public tariff. A registration fee is paid through the official portal (hple.moh.gov.et); candidates who miss a sitting without an accepted reason pay the registration fee plus a 50% penalty (MoH Exam Administration Manual). Confirm the current amount on the registration announcement. Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

EHPLE Pharmacy: Suggested Study Strategy

1Master the Ethiopian Standard Treatment Guidelines (STGs) for high-prevalence conditions including malaria (artemether-lumefantrine), tuberculosis (2RHZE/4RH), HIV (TLD regimen), hypertension, and diabetes.
2Focus on antimicrobial and autonomic pharmacology, understanding exact receptor mechanisms, resistance pathways, adverse drug event profiles, and critical drug interactions.
3Review pharmaceutics calculations and dosage form fundamentals, including powder properties, HLB values, sterile compounding cleanroom standards (ISO Class 5), and bioequivalence confidence intervals (80-125%).
4Study indigenous Ethiopian medicinal plants and their bioactive phytoconstituents, such as Hagenia abyssinica (kosotoxin), Phytolacca dodecandra (saponins), and Catha edulis (cathinone).
5Understand Ethiopian pharmaceutical supply chain systems and regulatory statutes, including IPLS reporting tools (RRF, bin cards), VEN/ABC matrix analysis, and EFDA Proclamation No. 1112/2019 provisions.

Frequently Asked Questions

What is the format and timing of the EHPLE Pharmacy examination?

The examination consists of 200 multiple-choice questions administered via computer-based testing (CBT). It is split in a morning and an afternoon block of 100 questions each (100 questions per session) separated by a scheduled recess, totaling Two 100-question blocks of testing time.

What is the passing score for the EHPLE Pharmacy exam?

The passing standard is not a fixed percentage; it is established for each examination round using the criterion-referenced Modified Angoff standard-setting methodology conducted by an expert panel from academia, practice, and the Ministry of Health.

Who is eligible to register for the EHPLE Pharmacy exam?

Graduates who have successfully completed all academic coursework and clinical clerkship requirements for a Bachelor of Pharmacy (BPharm) or BSc in Pharmacy degree from an accredited Ethiopian university or foreign-trained pharmacists whose credentials have been validated by the relevant education and health authorities.

What is the registration fee and process for the exam?

The examination fee is not published as a fixed public tariff and is announced by the Ministry of Health for each round; payable through designated electronic payment platforms (such as Telebirr) during the registration window on the official Ministry of Health licensure portal (https://hple.moh.gov.et/).

What core subjects and guidelines must candidates prepare for?

Preparation must be grounded in the official HHrIPR-LEO curriculum blueprint, emphasizing Pharmacology, Clinical Pharmacotherapy (including Ethiopian STGs for malaria, TB, and HIV), Pharmaceutics, Pharmaceutical Chemistry, Pharmacognosy (traditional Ethiopian medicinal plants), and EFDA regulatory/IPLS supply chain frameworks.

Are these practice questions an official EHPLE paper?

No. The EHPLE is set and delivered only by the Federal Ministry of Health; these questions are an independent study aid written against the official Information Booklet blueprint and Ethiopian national clinical guidelines. The official examination is delivered in English as computer-based, four-option, single-best-answer MCQs, so the item format here matches the real assessment, but this bank is not an official past paper, a released item pool, or a simulation of the live testing environment. Always confirm registration dates, fees, and exam-day rules on moh.gov.et/ehple and hple.moh.gov.et.